BLSM 8-K 2026-09-15

BlossomHill Therapeutics, Inc. (BLSM) 8-K dated 2026-09-15 — accession 0001193125-26-391328.

BlossomHill Therapeutics, Inc. (BLSM) common stock.

BlossomHill Therapeutics, Inc. filed a 8-K on 2026-09-15. Accession 0001193125-26-391328.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for BLSM is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The BLSM SEC hub lists recent forms. The stock page is the research view.